Working… Menu

Clinical Extension Study for Safety and Efficacy Evaluation of Cellavita-HD Administration in Huntington's Patients. (ADORE-EXT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04219241
Recruitment Status : Not yet recruiting
First Posted : January 7, 2020
Last Update Posted : January 13, 2020
Cellavita Pesquisa Científica Ltda
Information provided by (Responsible Party):
Azidus Brasil

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : January 2022
Estimated Study Completion Date : April 2022